Murex Announces Joint Development Agreement with GNS
News Jun 05, 2006
Murex Pharmaceuticals has announced its joint agreement with Gene Network Sciences (GNS) to develop cancer therapeutics.
Murex will utilize technology from GNS to create computer-based models that enhance identification and validation of cancer targets.
These computer models identify genes unique to an individual's malignancy. Murex identifies key alterations in cancer cells that dictate malignant growth.
GNS technology is integral in predicting which pathways are most significant in a patient's cancer. Murex then designs shRNA based vaccines to stop the cancer growth.
"We are very pleased to formalize our joint development agreement with Gene Network Sciences," said David Shanahan, president and CEO of Murex Pharmaceuticals.
"Together, we have proven the value of this technology and now move to integrate GNS into our development systems."
"We further expect that utilization of these 'in silico' inference models will enhance both the safety and efficacy of our products."
Murex Pharmaceuticals develops individualized cancer therapies using proprietary molecular analytics.
The integration of GNS technology, which uses computer models to study cancer therapies, brings unique insight to the complex interactions of these cellular processes.
"This marks the first time that biosimulation will be integral to the synthesis of therapies for cancer patients based on their individual gene expression data," said Colin Hill, CEO of Gene Network Sciences.
GNS scientists will work directly with Murex teams at Murex research and development facilities located in Dallas and Carrollton, Texas.
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018